Statistics (since 2007)

Status: Thursday, 08. January 2026

14674 completed cases

Male patients 6887 47%
Female patients 7787 53%
Children and youths 3565 24%
Adults 11109 76%

completed cases per country:

Germany 10828 74%
Austria 1228 8%
Switzerland 2618 18%

2900 completed cases

Male patients 1570 54%
Female patients 1330 46%
Children and youths 1194 41%
Adults 1706 59%

3705 completed cases

Male patients 2060 56%
Female patients 1645 44%
Children and youths 1452 39%
Adults 2253 61%

completed cases per country:

Brazil 282 8%
Bulgaria 256 7%
Greece 440 12%
Ireland 240 6%
Italy 974 26%
Poland 598 16%
Spain 705 19%
Romania 85 2%
Netherlands 92 2%
Croatia 33 1%

347 completed cases

Male patients 189 54%
Female patients 158 46%
Children and youths 305 88%
Adults 42 12%

Welcome

The Anaphylaxis Registry (NORA - Network for Online-Registration of Anaphylaxis) aims to collect data on severe allergic reactions. Since data collection began in 2007 across German-speaking countries, anaphylactic reactions have been continuously documented. Since 2011, NORA has been open internationally; since then, an average of around 1,300 cases per year have been recorded.
Overall, the most common triggers include insect venoms, foods, and medications—though their distribution differs between children (mainly foods) and adults (mainly insect venoms).
Anaphylaxis is a severe allergic reaction that can progress rapidly and may be fatal. An increase in anaphylactic reactions has been reported worldwide. Because anaphylactic reactions are not subject to mandatory reporting, there is no comprehensive official statistic on their frequency, course, and outcomes. In addition, modern life continually exposes people to new and sometimes unknown substances and environmental factors. Exotic foods, for example fruits, are imported from all over the world and consumed locally.
Within this project we aim to obtain information on triggers, cofactors, and treatment of patients who experienced a severe allergic reaction. Such data  will help to improve the knowledge and treatment modalities of affected patients.